Abeona Therapeutics (ABEO) Misses Q2 EPS by 4c
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Abeona Therapeutics (NASDAQ: ABEO) reported Q2 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $214 thousand versus the consensus estimate of $240 thousand.
For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Exelon Corp. (EXC) Tops Q3 EPS by 12c
- First Bank (FRBA) Tops Q3 EPS by 2c
- NeoGenomics (NEO) Tops Q3 EPS by 1c; Boosts FY16 EPS Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!